Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Micro Sclerostomy: First in Man (FIM) Safety and Preliminary Performance Study

NCT04484155 is registered in ClinicalTrials.gov with Sanoculis Ltd as lead sponsor.

NCT NCT04484155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04484155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Micro Sclerostomy: First in Man (FIM) Safety and Preliminary Performance Study
Lead sponsor
Sanoculis Ltd
Phase
Not applicable
Overall status
Completed
Start date
July 16, 2018
Completion date
March 5, 2020
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma